•
Jan 02, 2021

Transdigm Q1 2021 Earnings Report

Transdigm's Q1 2021 results were significantly impacted by the COVID-19 pandemic, but the EBITDA As Defined margin sequentially expanded due to careful cost management.

Key Takeaways

TransDigm Group reported a decrease in net sales by 24.4% to $1,108 million compared to the prior year's quarter. Income from continuing operations decreased by 78.6% to $50 million. Adjusted earnings per share were $1.97. The company's EBITDA As Defined margin was 42.8%.

Net sales decreased by 24.4% to $1,108 million.

Income from continuing operations was $50 million.

Adjusted earnings per share were $1.97.

EBITDA As Defined margin was 42.8%.

Total Revenue
$1.11B
Previous year: $1.47B
-24.4%
EPS
$1.97
Previous year: $4.93
-60.0%
Gross Profit
$541M
Cash and Equivalents
$4.91B
Previous year: $4.19B
+17.0%

Transdigm

Transdigm

Forward Guidance

Given the considerable uncertainty around the extent and duration of business disruptions related to the COVID-19 pandemic, and how that will impact operations, the Company will not provide fiscal year 2021 guidance at this time.